XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.19.1

Investment in Surface Pharmaceuticals, Inc. and Agreements - Related Party Transactions (Tables) - Surface Pharmaceuticals Inc [Member] | 3 Months Ended
--- | ---
Mar. 31, 2019
Schedule of Condensed Income Statement | The unaudited condensed results of operations information of Surface is summarized below:
|  | For the |
|  | Three Months Ended |
|  | March 31, 2019 |
Revenues, net |  | $ | - |
Loss from operations |  |  | 812 |
Net loss |  | $ | (812 | )
Schedule of Condensed Balance Sheet | The unaudited condensed balance sheet information of Surface is summarized below:
|  | March 31, |
|  | 2019 |
Current assets |  | $ | 18,742 |
Non current assets |  |  | 49 |
Total assets |  | $ | 18,791 |
Total liabilities |  | $ | 396 |
Total stockholders’ equity |  |  | 18,395 |
Total liabilities and stockholders’ equity |  | $ | 18,791 |

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=HROW_SurfacePharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |